Premium grade raw materials engineered to complement microbiological architectures across dietary supplements, functional foods, and advanced dermocosmetics.
A comprehensive examination of strain taxonomy, biological phenotype, metabolic kinetics, and stability profiling for global pharmaceutical and nutritional procurement directors.
Lactobacillus gasseri is a core human-autochthonous lactic acid bacterium (LAB) categorized within the Lactobacillus acidophilus complex. Our industrial strains undergo complete 16S rRNA gene sequencing and pulsed-field gel electrophoresis (PFGE) to guarantee zero genetic drift across commercial fermentation passages.
Unlike ordinary generic lactic cultures, Lactobacillus gasseri exerts distinct physiological actions via specialized surface layer proteins (SlpA), high-affinity bacteriocin production (Gassericin A & T), and conjugated linoleic acid (CLA) enzymatic isomerization capabilities.
Cell death in commercial freeze-dried probiotics occurs primarily through intracellular ice crystallization and lipid peroxidative damage. Our advanced strain stabilization integrates trehalose-lipid microencapsulation matrixes that shield the cell envelope during lyophilization.
| Analytical Parameter | Commercial Grade Spec | Pharma/High-Density Spec | Validation Methodology |
|---|---|---|---|
| Viable Cell Count (CFU/g) | ≥ 1.0 × 10¹¹ CFU/g (100B) | ≥ 5.0 × 10¹¹ CFU/g (500B) | ISO 19344 / IDF 232 (Flow Cytometry) & Plate Count |
| Physical Morphology | Off-white to light yellow powder | Uniform free-flowing micro-granules | Visual & Malvern Laser Particle Size Analysis |
| Moisture Content / Water Activity | Moisture ≤ 5.0%, Aw ≤ 0.18 | Moisture ≤ 3.5%, Aw ≤ 0.12 | Karl Fischer Titration / Chilled Mirror Dewpoint |
| Heavy Metals (Pb, As, Cd, Hg) | Total < 10.0 ppm; Pb < 0.5 ppm | Total < 2.0 ppm; Pb < 0.1 ppm | ICP-MS (USP <232> / <233>) |
| Enterobacteriaceae & Coliforms | < 10 CFU/g | Absent in 10g (Negative) | USP <2021> / FDA BAM |
| Pathogenic Staphylococci / Salmonella | Negative / 25g | Negative / 25g | Real-time PCR Confirmation (AOAC) |
Procuring bulk probiotic powders requires ironclad regulatory validation. We equip international product development and compliance teams with extensive documentation packages tailored to territorial jurisdiction guidelines.
For US dietary supplement and functional beverage integrators, our Lactobacillus gasseri strains feature comprehensive self-affirmed GRAS (Generally Recognized As Safe) dossiers reviewed by independent scientific panels, fulfilling 21 CFR § 170.30 standards alongside 21 CFR 111 cGMP validation.
Under European Food Safety Authority (EFSA) requirements, Lactobacillus gasseri holds Qualified Presumption of Safety (QPS) status. We furnish complete documentation verifying that commercial strains harbor no acquired antimicrobial resistance genes against critically important antimicrobials.
To serve expansive markets across Southeast Asia, the Middle East, and Latin America, our fermentation facilities undergo annual religious dietary audits. Fermentation feeds are formulated with pure vegetable peptones and glucose, eliminating bovine derivatives.
Harnessing state-of-the-art bio-fermentation clusters in Xi'an and precision freeze-drying infrastructure, we offer global partners unprecedented economies of scale, rigorous cold-chain integrity, and uninterrupted material continuity.
Automated SCADA-monitored bio-reactors enable precision pH control, fed-batch nutrient delivery, and high-density cultivation exceeding 10¹¹ CFU/mL upstream yield.
Industrial lyophilizers operate under automated sub-zero sublimation temperature curves, preserving bacterial membrane glycoproteins and enzymatic viability.
Integrated supply networks for fermentation media, agricultural carbohydrate sources, and energy infrastructure yield a 30-45% cost efficiency over Western counterparts.
Vacuum-sealed aluminum foil drums with multi-barrier nitrogen purge are shipped via refrigerated air and temperature-monitored marine containers with live GPS loggers.
From metabolic wellness to gynecological health, leading brands demand standardized potency, blend compatibility, and validated survivability. Here is how enterprise buyers deploy our Lactobacillus gasseri powder.
Targeted for weight management and metabolic syndrome supplements. Clinical research proves specific L. gasseri isolates downregulate lipid absorption, lower abdominal adiposity, and promote satiety peptide secretion (GLP-1).
As a dominant physiological resident of healthy vaginal microflora, L. gasseri actively generates lactic acid, stabilizing the local vaginal biome at pH 3.8–4.4 while producing targeted gassericins to displace BV and fungal pathogens.
Modern consumers demand active probiotic delivery beyond pills. We engineer micro-granulated, free-flowing L. gasseri powders designed specifically for direct-dissolve stick packs, powdered meal replacement shakes, and functional dairy.
As the probiotic market shifts from generic multi-strain blends to precision, clinically verified postbiotics and synbiotics, pharmaceutical innovators must align with key technical movements.
Thermal and ultrasonic inactivation of L. gasseri retains cellular lipoteichoic acid and surface peptides while removing moisture sensitivity. This enables long shelf-life in room-temperature ready-to-drink (RTD) teas, gummies, and confectionery snacks.
Enterprise brands no longer accept species-level declarations. Customers demand verified strain accession numbers deposited at international culture collections (ATCC, DSMZ, CGMCC) accompanied by peer-reviewed human clinical trials showing dose-dependent outcomes.
Groundbreaking metabolomic research indicates L. gasseri derived neurochemicals and short-chain fatty acids cross mucosal interfaces, dampening systemic low-grade inflammation, regulating hypothalamic leptin sensitivity, and enhancing metabolic tone.
Direct technical answers addressing viability assurance, analytical protocols, minimum order quantities, and OEM integration.
We deploy a multi-faceted preservation protocol. Upstream, bacteria are stabilized via multi-layer cryoprotectant matrixes (rich in trehalose and skim-milk fraction analogues) prior to deep lyophilization. The resulting powder is dried to Aw < 0.15 and immediately vacuum-sealed inside pharmaceutical multi-layer aluminum barrier pouches flushed with high-purity inert nitrogen gas. For global transit, we utilize validated insulated temperature-protective thermal shippers, dry ice, or refrigerated reefer containers backed by real-time calibrated digital temperature data-loggers.
Our standard MOQ for catalog strain specifications (100B, 200B CFU/g) is 1 kg, while custom strain concentrations (up to 500B CFU/g) or customized carrier formulations (Maltodextrin, Inulin, FOS, Resistant Starch) require a 5 kg to 25 kg minimum. Typical export production lead time is 7 to 14 business days. Every shipment is accompanied by a batch-specific Certificate of Analysis (COA), Technical Data Sheet (TDS), Safety Data Sheet (SDS), BSE/TSE-Free Statement, Non-GMO Attestation, Allergen Declaration, and flow cytometric viability release reports.
Yes. As a major bioscience manufacturer, we operate specialized Class 100,000 cleanroom blending suites equipped with 3D tumble mixers. We custom-blend Lactobacillus gasseri with complementary strains such as Lactobacillus rhamnosus, Lactobacillus reuteri, and Bifidobacterium lactis, as well as plant extracts, amino acids, and minerals (e.g., Magnesium L-Threonate, Phosphatidylserine, Zinc Glycinate) while monitoring water activity to prevent bacterial degradation.
Our release testing adheres to both traditional plating on MRS (de Man, Rogosa and Sharpe) agar according to ISO 19344 / IDF 149 standards, and rapid fluorogenic flow cytometry to quantify Total Cell Units (TFU) alongside Active Fluorescent Units (AFU). This provides customers with complete verification of colony-forming viability and ensures full compliance with international pharmacopeial standards.
When stored in original unopened packaging at -18°C (frozen), our Lactobacillus gasseri powder is guaranteed for 24 to 36 months with <0.1 log loss per year. When maintained under cool refrigerated storage (4°C to 8°C), stability is warranted for 24 months. For ambient retail products (25°C / 60% RH), our microencapsulated grade maintains label claim when formulated with our recommended overage (typically 15-20%) over an 18-month commercial shelf cycle.
Complementary high-purity active ingredients sourced by tier-one nutraceutical formulators worldwide. Validated by HPLC, LC-MS, and USP/FCC monographs.